AwardedPRTGoods€5,461,760
Aquisiçao do Medicamento: Axicabtagene ciloleucel 0.4 - 2 x10e8 células Disp inj Fr 68 ml IV
- Published
- Published 3 April 2026
Overview
Aquisiçao do Medicamento:
Axicabtagene ciloleucel 0.4 - 2 x10e8 células Disp inj Fr 68 ml IV
Key details
- Country
- PRT
- Status
- Awarded
- Category
- Goods
- Estimated value
- €5,461,760
- Procedure
- Direct
- Published
- 3 April 2026
Pharmaceutical products
Award outcome
- Awarded value
- €5,461,760
- Award date
- 19 February 2026
- Contract period
- — → 14 February 2027
- Gilead Sciences, Lda
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
3 April 2026
Contracting authority
Instituto Português de Oncologia do Porto Francisco Gentil, EPE
Procuring entityPorto, PRT
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.